These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 98234)
1. [Treatment of acute leukaemia and medullary inhibition in aseptic environment (author's transl)]. Bláha M; Vanásek J; Mĕrka V; Erichleb M; Splino M; Siroký O; Mazák J; Hrncír Z; Malý J Cas Lek Cesk; 1978 Jun; 117(22-23):698-701. PubMed ID: 98234 [No Abstract] [Full Text] [Related]
2. [Treatment of patients with acute leukemia and chemically-induced depression of hematopoiesis under aseptic conditions]. Blaga M; Vaniasek Ia; Merka V; Mazak Ia; Grnchirzh Z Probl Gematol Pereliv Krovi; 1977 Sep; 22(9):57-8. PubMed ID: 412184 [No Abstract] [Full Text] [Related]
3. [Chemotherapy of acute leukemia in a bioclean system (author's transl)]. Uetani T; Ono R; Yamada K Rinsho Ketsueki; 1974 Apr; 15(4):384-92. PubMed ID: 4858891 [No Abstract] [Full Text] [Related]
4. [Infection prevention in acute leukemia under protected environment (author's transl)]. Nagao T; Komatsuda M; Watanabe K; Nozaki H; Yamauchi K; Arimori S Rinsho Ketsueki; 1980 Jul; 21(7):961-7. PubMed ID: 7420745 [No Abstract] [Full Text] [Related]
5. [Progress in treatment of acute leukemia using bioclean room (author's transl)]. Nagai K Rinsho Ketsueki; 1977 May; 18(5):545-54. PubMed ID: 904077 [No Abstract] [Full Text] [Related]
6. Prevention of infection with protected environment and prophylactic antibiotics in the therapy of acute leukemia. Nagao T; Watanabe K; Nozaki H; Komatsuda M; Arimori S Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):78-85. PubMed ID: 6797215 [No Abstract] [Full Text] [Related]
7. [Oral cavity focal infection in blood diseases in reverse isolation in aseptic environment (author's transl)]. Bartáková V; Bláha M; Hrncír Z Cas Lek Cesk; 1976 Aug; 115(33-34):1035-7. PubMed ID: 975175 [No Abstract] [Full Text] [Related]
8. [Therapy of acute leukoses]. Stacher A Wien Med Wochenschr; 1973 Sep; 123(38):549-54. PubMed ID: 4201578 [No Abstract] [Full Text] [Related]
9. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. Levine AS; Siegel SE; Schreiber AD; Hauser J; Preisler H; Goldstein IM; Seidler F; Simon R; Perry S; Bennett JE; Henderson ES N Engl J Med; 1973 Mar; 288(10):477-83. PubMed ID: 4630706 [No Abstract] [Full Text] [Related]
10. [Bacteriological investigations on patients with acute leukemia under protective environment (author's transl)]. Nagao T; Katanabe K; Komatsuda M; Arimori S Rinsho Ketsueki; 1979 Jan; 20(1):8-14. PubMed ID: 423377 [No Abstract] [Full Text] [Related]
11. [Distribution of 159 cases of acute non-lymphoblastic leukaemia (ANLL) according to the FAB classification, and prognostic correlations (author's transl)]. Sanz MA; Amigo V; Gomis F; Pérez Sirvent ML; Besalduch J; Rafecas J; Martinez J; Marty ML Sangre (Barc); 1981; 26(5-C):1019-25. PubMed ID: 7323923 [No Abstract] [Full Text] [Related]
12. [Treatment of acute leukemia with newly synthesized N4-behenoyl-l-beta-D-arabinofuranosylcytosine (BH-AC) (author's transl)]. Sueyama H; Oguro M; Takagi T Rinsho Ketsueki; 1981 Jul; 22(7):1109-15. PubMed ID: 7328768 [No Abstract] [Full Text] [Related]